Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort studySusana Monge, Virgilio Yagüe Galaup, Ayelén Rojas‐Benedicto et al.|The Lancet Infectious Diseases|2022Cited by 84
Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case–control study, Spain, 2023/24 seasonOlivier Núñez, Marcos Alonso-García, Pello Latasa Zamalloa et al.|Eurosurveillance|2025Cited by 25
Effectiveness of a Second Dose of an mRNA Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in Individuals Previously Infected by Other VariantsSusana Monge, Virgilio Yagüe Galaup, Ayelén Rojas‐Benedicto et al.|Clinical Infectious Diseases|2022Cited by 9
Nirsevimab Effectiveness Against Rsv Hospital Admission in Children Under 1 Year of Age: A Spanish Population-Based Case Control StudyOlivier Núñez, Susana Monge, Carmen Olmedo et al.|SSRN Electronic Journal|2024Cited by 4